Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

Ultiva 1 mg (December 21, 2007)

Report a Concern
Starting date:
December 21, 2007
Posting date:
January 07, 2008
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-2008A1

Reason

Product label have a printing defect where a small area of ink was not transferred onto the vial label. This defect, the size of a decimal point, appears on certain labels directly before the Ultiva strength (1 mg) and may be mistaken for 0.1 mg instead of 1 mg

Depth of distribution

Wholesalers, Hospital pharmacies and Clinics in Canada only. No exportation.

Affected products

Ultiva 1 mg

DIN, NPN, DIN-HIM

DIN 02230409

Dosage form

Powder for solution

Strength

  • 1 mg

Lot or serial number

49290DD, 52185DD, 56275DD

Companies

Recalling Firm
Abbott Laboratories Ltd.
8401 Trans Canada Highway
Saint-Laurent Quebec
Canada H4S 1Z1
Marketing Authorization Holder
Abbott Laboratories Ltd.
8401 Trans Canada Highway
Saint-Laurent Quebec
Canada H4S 1Z1